Cancer Australia Lung Cancer Screening enquiry

Closed 17 Feb 2020

Opened 9 Dec 2019

Published Responses

View submitted responses where consent has been given to publish the response.


The Lung Cancer Screening enquiry Consultation Hub is now closed. Cancer Australia thanks all those who contributed to the enquiry through the public consultation. Further information will be posted here shortly. 

Cancer Australia is inviting the public to have their say about the Lung Cancer Screening enquiry through this dedicated Consultation Hub.

On 1 August 2019, the Minister for Health, the Hon Greg Hunt MP invited Cancer Australia to conduct an enquiry into the prospects, process and delivery of a national lung cancer screening program in Australia.

The enquiry is being held to investigate the feasibility for a national lung cancer screening program for people at high risk of lung cancer. This will include a review of national and international evidence on the benefits and harms of lung cancer screening, target population groups, and the design and effective delivery of a national lung cancer screening program in the Australian setting.

Early diagnosis of lung cancer is critical to improving outcomes, with more than 50% of lung cancer cases being diagnosed at an advanced stage. Advanced stage at diagnosis is associated with poorer survival. Lung cancer is the leading cause of cancer death in Australia, accounting for nearly 1 in 5 of all cancer deaths.

Cancer Australia will provide a report on the Lung Cancer Screening enquiry to the Minister by October 2020.

Why We Are Consulting

Cancer Australia is undertaking a broad consultation process through the Consultation Hub, to seek views and input across all sectors of the Australian community on the Lung Cancer Screening enquiry.

The consultation is being held to seek feedback from members of the public, Aboriginal and Torres Strait Islander communities,  people affected by cancer, health professionals, clinical colleges, researchers and research institutes, cancer organisations, peak bodies and governments.

Submissions are also invited from population groups who could benefit most from lung cancer screening due to reasons such as remoteness, language, culture, age or mobility.

All interested stakeholders are invited to have your say.

How to have your say

Download and read a Have your say on the Lung Cancer Screening enquiry consultation paper at the foot of this page for:

  • Community and individuals
  • Stakeholder groups and organisations.

You can choose to have your say in one or both of two ways through the Online Survey:

  1. open submission 
  2. direct response to questions.

Questions to consider

You may find it helpful to consider the following questions to help frame your submission, or choose to answer the questions directly by going to our Online survey.

  1. What, in your opinion, are the most important issues that should be considered for a screening program for people at high risk of lung cancer?
  2. If a national lung cancer screening program were introduced for people at high risk of lung cancer, what do you think are the best ways to engage and recruit them to participate?
  3. What do you see as the practical challenges and opportunities in delivering a national lung cancer screening program for people at high risk of lung cancer in Australia?
  4. Do you have any other comments or suggestions about lung cancer screening or the enquiry?

If you experience any technical issues or have any questions about completing the Online Survey, please contact

How we will use your responses

The feedback we receive from these online submissions will help to:

  • inform what Cancer Australia does in the conduct of the enquiry
  • contribute to the enquiry activities.

Help to have your say

If you need an interpreter, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Information in a range of languages is available at the foot of this page. 

If you have any questions or concerns about the survey, please email

Privacy information

Your personal information is protected by law, including the Privacy Act 1988 and the Australian Privacy Principles. It is being collected by Cancer Australia for the purpose of public consultation about the Lung Cancer Screening enquiry.

If you have provided consent to publish, your submission will be published on this Consultation Hub within a few days.

 Responses may be moderated to remove content that is inappropriate, offensive, or contains sensitive information.

Please note that your email address will not be published.

What Happens Next

Where consent to publish submissions has been provided, these will be made public on the Consultation Hub.

Stay informed

Information and updates about the Lung Cancer Screening enquiry are available on the Lung Cancer Screening enquiry webpage on Cancer Australia’s website (


  • Aboriginal and Torres Strait Islander People
  • Seniors
  • Men
  • Women
  • Carers and guardians
  • Families
  • Academics
  • Non-government organisations
  • State government agencies
  • Commonwealth agencies
  • Health professionals
  • Health workforce
  • General public
  • Community groups


  • Hospitals
  • e-Health
  • Health technology
  • Medicare
  • Legislation
  • Health insurance
  • Rural health services
  • Regulatory policy
  • Women's health
  • Alcohol
  • Tobacco
  • Chronic disease
  • Mental health
  • Drugs and substance abuse
  • Aboriginal and Torres Strait Islander health
  • Environmental health
  • Preventative health
  • Strategic Policy
  • Policy Development